Antineoplastic AgentsSensitivity and SpecificityRadiation DosageRadiation, IonizingRadiation InjuriesDose-Response Relationship, RadiationRadiation ToleranceRadiationCell Line, TumorDrug Screening Assays, AntitumorRadiation ProtectionRadiation MonitoringNeoplasmsDoxorubicinApoptosisDrug Resistance, NeoplasmCell SurvivalRadiation OncologyAntineoplastic Agents, PhytogenicCisplatinAntibiotics, AntineoplasticTumor Cells, CulturedGamma RaysDrug Delivery SystemsCosmic RadiationDNA DamageRadiation Injuries, ExperimentalXenograft Model Antitumor AssaysMice, NudeRadiation PneumonitisDrug CarriersDose-Response Relationship, DrugUltraviolet RaysRadiation-Sensitizing AgentsNeoplasms, Radiation-InducedCell ProliferationRadiotherapyTime FactorsEllipticinesBackground RadiationInhibitory Concentration 50EtoposidePaclitaxelCamptothecinDrug Resistance, MultipleCombined Modality TherapyBreast NeoplasmsP-GlycoproteinRadiation EffectsRadiometryRadiotherapy DosageMolecular StructureCell CycleDrug SynergismDNA RepairDrug DesignEnzyme InhibitorsRadiation-Protective AgentsDNA Topoisomerases, Type IIGene Expression Regulation, NeoplasticReproducibility of ResultsSignal TransductionMutationProdrugsModels, BiologicalDrug ResistanceDNAFluorouracilMolecular Sequence DataDrug Evaluation, PreclinicalTopoisomerase I InhibitorsTumor Suppressor Protein p53DaunorubicinNanoparticlesContrast SensitivityCell LineAcute Radiation SyndromeAntimetabolites, AntineoplasticColonic NeoplasmsNanomedicinePlatinumBlotting, WesternX-RaysPlant ExtractsCell DivisionCaspasesNeoplasm TransplantationNeoplasms, ExperimentalProto-Oncogene Proteins c-bcl-2Antineoplastic Combined Chemotherapy ProtocolsFlow CytometryDrug DiscoveryMitomycinNanocapsulesCobalt RadioisotopesCell DeathCaspase 3Antineoplastic Agents, AlkylatingNeoplasm ProteinsOrganoplatinum Compounds